Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology
about
Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytesYoung at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingTissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screeningConsiderations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesConcise review: growing hearts in the right place: on the design of biomimetic materials for cardiac stem cell differentiationEnhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat HeartsInduced pluripotent stem cell-derived cardiac progenitors differentiate to cardiomyocytes and form biosynthetic tissuesMicro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assayStrategies and Challenges to Myocardial Replacement TherapyModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesMaturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues2D and 3D self-assembling nanofiber hydrogels for cardiomyocyte culture.Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.Three-dimensional filamentous human diseased cardiac tissue model.Automated analysis of contractile force and Ca2+ transients in engineered heart tissue.Machine learning plus optical flow: a simple and sensitive method to detect cardioactive drugsDirect hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues.Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue.Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell TherapyNaturally Engineered Maturation of CardiomyocytesBiomechanical regulation of in vitro cardiogenesis for tissue-engineered heart repair.Three-dimensional paper-based model for cardiac ischemiaBioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation.Effects of proarrhythmic drugs on relaxation time and beating pattern in rat engineered heart tissue.Complex interactions between human myoblasts and the surrounding 3D fibrin-based matrix.Trends in cardiovascular engineering: organizing the human heart.FHL2 expression and variants in hypertrophic cardiomyopathy.Human stem cells for modeling heart disease and for drug discovery.Human Cardiac Tissue Engineering: From Pluripotent Stem Cells to Heart Repair.Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes.A phenotypic in vitro model for the main determinants of human whole heart function.Prospects for In Vitro Myofilament Maturation in Stem Cell-Derived Cardiac Myocytes.Biomaterial based cardiac tissue engineering and its applicationsHuman Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.Electrical and Mechanical Strategies to Enable Cardiac Repair and Regeneration.Thick acellular heart extracellular matrix with inherent vasculature: a potential platform for myocardial tissue regeneration
P2860
Q24623082-8410DC7F-85D2-454B-864F-1ED1D6E42C1CQ26750663-FA20FEF8-04EB-4B90-9E7C-4868DDB890B3Q26772221-897E74A2-F526-47E3-AFD4-5ED6C97D1080Q26799470-127AC952-A87E-4D2B-9549-EC1BE6E12544Q26865173-587B3427-E5E3-46C2-B5AD-99DB01DD9D01Q27014904-161C7441-D8DB-43EE-8B8F-3231E6D2FDC4Q27303626-4B48B1CF-7B49-4DDE-973A-347BF48AD7C0Q27315974-493DCE86-2F6F-4D06-9924-72714E266DDCQ27341916-09D22805-2A9A-4849-B1AD-6EAD5FDC9F07Q28068007-84E567E7-C2E6-496A-888F-48EDCD62CA1DQ28255887-6FB0ACAB-011F-476D-9210-EB145066705CQ28550738-CC8C4C00-7B83-475C-BC65-26EB9F7E18D1Q30537357-751BB0A3-9776-442E-A387-D7D368D73235Q30559093-7BFF5859-7F34-4B93-8650-73AE98E4FB3FQ30566351-5C5EA3F5-9145-4B85-ADB5-97E95255CB07Q30567430-CFA9DA32-39F0-4DB7-AC35-887F1FDFB00FQ30585420-902E9168-7731-40A1-A95F-7F0031CE6100Q30656460-A445236D-8E5C-4811-908B-E879F11F06CAQ30731784-E98A57BA-2B03-4707-97B5-657F101D9B95Q30843677-26BADBDB-50C1-4A12-92A1-BF6347DDA10FQ31056955-BC5ABD70-1F16-4578-B0BD-61F3992F03C3Q33639096-F4B012EC-6D9B-40C6-B055-4C387102F5DFQ33746344-2D426031-85DB-43E3-9801-F84AD58BC097Q33934409-FBD8B7CE-F9C7-4FB2-9742-BAFB44944D12Q33939491-CD58C7E8-74C1-4685-9C9E-A080910898A2Q34161831-8E671FD0-2B2D-4A5C-85D9-E53678C56C2FQ34257262-58A36DBF-6283-4B26-A352-B89D70E65EC4Q34347650-6BC980A0-2B60-4069-9B3D-3195ADDD6FFEQ34430364-1301C511-15B3-4816-B2A3-CF889AAEB786Q34433363-71148802-464C-4358-9B1E-F0568495245CQ34947905-4EB5AE56-4394-4EC5-8561-A8F42A04E5CCQ35049000-76AB2F84-1DE7-4F13-AC3F-07F56E774195Q35232473-C90931B7-3220-490B-8496-F74D8BDB6FBCQ35414785-BAB14EFB-5244-4109-A473-8855C9BCB078Q35690281-51DA7B27-E28B-49BF-8E03-4D475D8DDD1FQ35724421-A742115C-20F1-4A88-A259-BA3EACCACBDAQ35731251-52DB3775-29DF-4417-9620-1B34801AD273Q35897783-1219D4E7-F5E6-4A46-BA8C-68C51D49A0B2Q36083735-757C2766-17AD-4BEC-8C8F-8B2D1DD98B8EQ36294610-2DDC16D2-85D9-4A46-87B0-3B401EEAD39E
P2860
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Human engineered heart tissue ...... rch and preclinical toxicology
@ast
Human engineered heart tissue ...... rch and preclinical toxicology
@en
Human engineered heart tissue ...... rch and preclinical toxicology
@en-gb
Human engineered heart tissue ...... rch and preclinical toxicology
@nl
type
label
Human engineered heart tissue ...... rch and preclinical toxicology
@ast
Human engineered heart tissue ...... rch and preclinical toxicology
@en
Human engineered heart tissue ...... rch and preclinical toxicology
@en-gb
Human engineered heart tissue ...... rch and preclinical toxicology
@nl
altLabel
Human Engineered Heart Tissue ...... rch and Preclinical Toxicology
@en
prefLabel
Human engineered heart tissue ...... rch and preclinical toxicology
@ast
Human engineered heart tissue ...... rch and preclinical toxicology
@en
Human engineered heart tissue ...... rch and preclinical toxicology
@en-gb
Human engineered heart tissue ...... rch and preclinical toxicology
@nl
P2093
P2860
P3181
P1433
P1476
Human engineered heart tissue ...... rch and preclinical toxicology
@en
P2093
Alexandra Eder
Andrea Stöhr
Arne Hansen
Aya Shibamiya
Lenard Conradi
Marc N Hirt
Marco Mewe
Sebastian Schaaf
Thomas Eschenhagen
Thomas Rau
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0026397
P407
P577
2011-01-01T00:00:00Z